Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs Roundhill S&P 500 0DTE Covered Call Strategy ETF (XDTE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.32 (market cap $2.27B), while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $38.55 (market cap $330.98M). The key difference: SELLAS Life Sciences Group Inc. Common Stock is far larger — about 6.9× Roundhill S&P 500 0DTE Covered Call Strategy ETF's market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, Roundhill S&P 500 0DTE Covered Call Strategy ETF nearer its low. Which is the better fit depends on your goals.
| SLS | XDTE | |
|---|---|---|
Market Cap | $2.27B | $330.98M |
Volume | 4,179,659 | 194,030 |
Sector | Health | Income / Options Overlay |
52-Week High | $15.46 | $44.76 |
52-Week Low | $1.39 | $36.00 |
Enterprise Value | $2.14B | — |
Typical Hold Time | — | 54 Days |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About Roundhill S&P 500 0DTE Covered Call Strategy ETF
XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →
